| January 1, 2027 |
INCY |
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation |
Trial Milestone |
Phase 1 |
| January 2, 2027 est. |
ANGO |
Next quarterly earnings (projected) |
Earnings |
— |
| January 4, 2027 |
INCY |
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease |
Trial Milestone |
Phase 1 |
| January 4, 2027 |
MLTX |
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response |
Trial Milestone |
Phase 3 |
| January 6, 2027 |
INCY |
A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD |
Trial Milestone |
Phase 1/Phase 2 |
| January 7, 2027 |
IDYA |
Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion |
Trial Milestone |
Phase 1 |
| January 8, 2027 |
OCUL |
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration |
Trial Milestone |
Phase 3 |
| January 9, 2027 |
MRNA |
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations |
Trial Milestone |
Phase 4 |
| January 11, 2027 est. |
JNJ |
Next quarterly earnings (projected) |
Earnings |
— |
| January 13, 2027 est. |
NRIX |
Next quarterly earnings (projected) |
Earnings |
— |
| January 14, 2027 |
NVO |
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity |
Trial Milestone |
Phase 2 |
| January 15, 2027 |
ABBV |
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC) |
Trial Milestone |
Phase 2/Phase 3 |
| January 15, 2027 |
ABBV |
Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis |
Trial Milestone |
Phase 1 |
| January 15, 2027 |
ABBV |
Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma |
Trial Milestone |
Phase 1 |
| January 15, 2027 |
ABBV |
A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Adult Japanese Participants With Overweight or Obesity. |
Trial Milestone |
Phase 1 |
| January 15, 2027 |
NVO |
A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure |
Trial Milestone |
Phase 1 |
| January 15, 2027 |
SVA |
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months |
Trial Milestone |
Phase 3 |
| January 15, 2027 |
RARE |
Setrusumab in Pediatric Japanese Subjects With Osteogenesis Imperfecta |
Trial Milestone |
Phase 3 |
| January 15, 2027 |
MIRM |
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis |
Trial Milestone |
Phase 2 |
| January 15, 2027 |
PRAX |
Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures |
Trial Milestone |
Phase 3 |
| January 15, 2027 |
XENE |
An Open-Label Study of Azetukalner in Major Depressive Disorder |
Trial Milestone |
Phase 3 |
| January 15, 2027 |
IDYA |
IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma |
Trial Milestone |
Phase 2/Phase 3 |
| January 15, 2027 |
TEVA |
A Trial to Assess TEV-56286 at Different Doses in Healthy Participants |
Trial Milestone |
Phase 1 |
| January 15, 2027 |
PCVX |
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49 |
Trial Milestone |
Phase 3 |
| January 15, 2027 |
RCUS |
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies |
Trial Milestone |
Phase 2 |
| January 15, 2027 |
NRIX |
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies |
Trial Milestone |
Phase 1 |
| January 15, 2027 |
EWTX |
A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX) |
Trial Milestone |
Phase 2 |
| January 15, 2027 |
ELDN |
Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant |
Trial Milestone |
Phase 1/Phase 2 |
| January 15, 2027 |
KURA |
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors |
Trial Milestone |
Phase 1 |
| January 15, 2027 |
PCRX |
Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery |
Trial Milestone |
Phase 1 |
| January 15, 2027 |
LRMR |
An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia |
Trial Milestone |
Phase 2 |
| January 15, 2027 |
SGMT |
Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne |
Trial Milestone |
Phase 1 |
| January 15, 2027 |
LXRX |
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy |
Trial Milestone |
Phase 3 |
| January 15, 2027 |
XBIT |
Natrunix in Combination With Methotrexate for Rheumatoid Arthritis Treatment |
Trial Milestone |
Phase 2 |
| January 15, 2027 |
CGEM |
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) |
Trial Milestone |
Phase 1 |
| January 16, 2027 |
CRBP |
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors |
Trial Milestone |
Phase 1/Phase 2 |
| January 18, 2027 |
PFE |
Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. |
Trial Milestone |
Phase 3 |
| January 20, 2027 |
TTRX |
A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema) |
Trial Milestone |
Phase 2/Phase 3 |
| January 20, 2027 |
CELZ |
Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain |
Trial Milestone |
Phase 1/Phase 2 |
| January 21, 2027 |
AMGN |
Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight |
Trial Milestone |
Phase 3 |
| January 21, 2027 |
AMGN |
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight |
Trial Milestone |
Phase 3 |
| January 21, 2027 |
NVO |
A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity |
Trial Milestone |
Phase 1 |
| January 21, 2027 |
TGTX |
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab |
Trial Milestone |
Phase 3 |
| January 22, 2027 |
ADRX |
Phase 1 Study of ADX-626 in Healthy Participants |
Trial Milestone |
Phase 1 |
| January 26, 2027 |
NVO |
A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese |
Trial Milestone |
Phase 1 |
| January 28, 2027 |
MRNA |
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults |
Trial Milestone |
Phase 3 |
| January 29, 2027 |
IDYA |
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions |
Trial Milestone |
Phase 1/Phase 2 |
| January 30, 2027 |
SVA |
Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen |
Trial Milestone |
Phase 3 |
| January 31, 2027 |
NVO |
A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity |
Trial Milestone |
Phase 1 |
| January 31, 2027 |
EXEL |
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors |
Trial Milestone |
Phase 1 |
| January 31, 2027 |
QNRX |
Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome |
Trial Milestone |
Phase 2/Phase 3 |
| January 31, 2027 |
BSX |
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM |
Trial Milestone |
Phase 1 |
| January 31, 2027 |
CELZ |
Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes |
Trial Milestone |
Phase 1/Phase 2 |